CooperVision Showcases Myopia Control, Ortho-K, and Scleral Contact Lens Leadership at GSLS 2022

CooperVision and its Specialty EyeCare unit will present a comprehensive portfolio of products, services and resources at the 2022 Global Specialty...

Read More

Seven-Year MiSight® 1 day Contact Lens Study Indicates No Myopia Control Rebound in Children

CooperVision announced new seven-year findings from its pivotal MiSight® 1 day contact lens clinical trial Twelve months following treatment...

Read More
2021 Myopia Report available

2021 Canadian ECP Myopia Study results now available

The 2021 Myopia study final report of Canadian ECPs attitudes is now available The purpose of the Canadian Myopia Management ECP study is to...

Read More

CooperVision: SightGlass Vision Diffusion Optics Technology Demonstrates Significant Reduction in Myopia Progression

CooperVision’s SightGlass Vision Business has revealed two-year clinical study data for its Diffusion Optics Technology™, which is specifically...

Read More
2021 Myopia Report available

Canadian ECP Myopia Survey Now Available

The 2021 Canadian ECPs survey on the usage of and attitudes towards myopia control therapies in now available Click Here to start the survey ...

Read More
1 11 12 13 14 15 29